A DRUG originally developed to treat cancer has been found to dramatically reduce scarring of the eye. In theory, the drug should also reduce scarring in other tissues, including the skin.
Studies by a team led by Peng Tee Khaw at the Moorfields Eye Hospital in London suggest that the drug Ilomastat can reduce scarring by as much as 80 per cent, and that the healed area has a more normal structure. “This is a dramatic reduction in scar tissue,” says Khaw. And since the same scarring mechanism controls the way tissues heal throughout the body, he says, the drug…
